The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.
Jan 19 () - Pharmaceutical company Boehringer Ingelheim said on Monday the U. Food and Drug ​Administration had approved its ...
Heart failure is a condition in which the heart doesn’t pump blood as well as it should. While the term “heart failure” (also known as congestive heart failure ) may sound like the heart has stopped ...
Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...